Experimental validation confirms the ability of artificial intelligence to accelerate drug discovery
Insilico Medicine, a global leader in artificial intelligence for drug discovery, has announced the publication of a paper titled, “Deep learning enables rapid identification of potent DDR1 kinase inhibitors,” in…